Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid

Pediatric Infectious Disease Journal

Volumn 22, Issue 12, 2003, Pages 1101-1103

  Ang, Jocelyn Y ^a   Lua, Jorge L ^a   Turner, Daniel R ^a   Asmar, Basim I ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endocarditis; Linezolid; Neonate; Vancomycin resistant enterococcus

Indexed keywords

AMPICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; CENTRAL VENOUS CATHETER; ENTEROCOCCUS FAECIUM; HOSPITAL INFECTION; HUMAN; INFANT; MALE; PREMATURITY; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TRICUSPID VALVE DISEASE; VASCULAR ACCESS;

ACETAMIDES; ANTI-INFECTIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECIUM; FOLLOW-UP STUDIES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; RISK ASSESSMENT; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE;

EID: 0346120133     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000101784.83146.0c     Document Type: Article

References (20)

1. Dobson, SRM, Baker CJ. Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics 1990;85:165-71.
2. Luginbuhl LM, Rotbart HA, Facklam RR, et al. Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J 1987;6:1022-30.
3. Landman D, Quale JM. Management of infections due to resistant enterococci: a review of therapeutic options. J Antimicrob Chemother 1997;40:161-70.
4. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR 42:597-9.
5. Huycke MM, Sahm. DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis 1998;4:239-49.
6. Babcock HM, Ritchie DJ, Christiansen E, et al. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis 2001;32:1373-5.
7. Chien JW, Kucia ML, Salata RA. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant Gram-positive bacterial infections. Clin Infect Dis 2000;30:146-51.
8. Rao N. Successful treatment of Enterococcus faecalis prosthetic valve endocarditis with linezolid. Clin Infect Dis 2002;35:902-4.
9. Birmingham MC, Rayner CR, Meagher AK, et al. Linezolid for the treatment of multidrug-resistant, Gram-positive infections: experience from a compassionate-use program. Clin Infect Dis 2003;36:159-68.
10. Graham LP III, Ampofo K, Saiman L, et al. Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis. Pediatr Infect Dis J 2002;21:798-800.
11. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001;139:821-7.
12. Yuce A, Karaman M, Gulay Z, et al. Vancomycin-resistant enterococci in neonates. Scand J Infect Dis 2001;33:803-5.
13. Singh-Naz N, Rakowsky A, Cantwell E, et al. Nosocomial enterococcal infections in children. J Infect 2000;40:145-9.
14. Rubin LG, Tucci V, Cercenado E, et al. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-5.
15. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002;8:802-7.
16. Coudron PE, Mayhall CG, Facklam RR, et al. Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol 1984;20:1044-8.
17. Gordon S, Swenson JM, Hill BC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992;30:2373-8.
18. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001;358:1975-82.
19. Jones RN, Ballow CH, Biedenbach DJ, et al. Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States. Diagn Microbiol Infect Dis 2001;40:59-66.
20. Zeana C, Kubin CJ, Della-Latta P, et al. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis 2001;33:477-82.